PY0300568A - Metabolitos del acido(3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi)acetico - Google Patents
Metabolitos del acido(3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi)aceticoInfo
- Publication number
- PY0300568A PY0300568A PY200300300568A PY0300568A PY0300568A PY 0300568 A PY0300568 A PY 0300568A PY 200300300568 A PY200300300568 A PY 200300300568A PY 0300568 A PY0300568 A PY 0300568A PY 0300568 A PY0300568 A PY 0300568A
- Authority
- PY
- Paraguay
- Prior art keywords
- butylbenzyl
- pyridin
- metabolites
- sulfonyl
- phenoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invencion se refiere a metabolitos del acido (3-{[4-terc-butilbencil)-(piridin-3-sulfonil]amino]metil}fenoxi)acetico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35374802P | 2002-01-31 | 2002-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PY0300568A true PY0300568A (es) | 2004-10-01 |
Family
ID=27663249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PY200300300568A PY0300568A (es) | 2002-01-31 | 2003-01-14 | Metabolitos del acido(3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi)acetico |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6852863B2 (es) |
| EP (1) | EP1470109A1 (es) |
| JP (1) | JP2005521668A (es) |
| KR (1) | KR20040077884A (es) |
| CN (1) | CN1625549A (es) |
| AP (1) | AP2004003094A0 (es) |
| AR (1) | AR038332A1 (es) |
| BR (1) | BR0307339A (es) |
| CA (1) | CA2473984A1 (es) |
| EA (1) | EA200400724A1 (es) |
| EC (1) | ECSP045215A (es) |
| GB (1) | GB2400100B (es) |
| HN (1) | HN2003000051A (es) |
| HR (1) | HRP20040683A2 (es) |
| HU (1) | HUP0500012A2 (es) |
| IL (1) | IL162167A0 (es) |
| IS (1) | IS7281A (es) |
| MA (1) | MA27169A1 (es) |
| MX (1) | MXPA04004960A (es) |
| NO (1) | NO20043569D0 (es) |
| OA (1) | OA12760A (es) |
| PA (1) | PA8564601A1 (es) |
| PE (1) | PE20030978A1 (es) |
| PL (1) | PL371982A1 (es) |
| PY (1) | PY0300568A (es) |
| TN (1) | TNSN04138A1 (es) |
| TW (1) | TW200302080A (es) |
| UY (1) | UY27632A1 (es) |
| WO (1) | WO2003064391A1 (es) |
| ZA (1) | ZA200404067B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
| US7666330B2 (en) * | 2005-04-20 | 2010-02-23 | Lg Chem, Ltd. | Additive for non-aqueous electrolyte and secondary battery using the same |
| AU2007280130B2 (en) * | 2006-07-28 | 2011-09-22 | Pfizer Products Inc. | EP2 agonists |
| EP2126574B1 (en) | 2007-03-08 | 2015-12-23 | The Board of Trustees of the Leland Stanford Junior University | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
| EP2002834A1 (de) * | 2007-06-13 | 2008-12-17 | Bayer Schering Pharma Aktiengesellschaft | Aryl/Hetarylamide als Modulatoren des EP2-Rezeptors |
| SI2264009T1 (sl) * | 2008-03-12 | 2019-05-31 | Ube Industries, Ltd. | Spojina piridilaminoocetne kisline |
| EP2149551A1 (de) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | N-(Indol-3-ylalkyl)-(hetero)arylamidderivate als Modulatoren des EP2-Rezeptors |
| EP2149554A1 (de) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma Aktiengesellschaft | Indolylamide als Modulatoren des EP2-Rezeptors |
| EP2149552A1 (de) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | 5,6 substituierte Benzamid-Derivate als Modulatoren des EP2-Rezeptors |
| WO2010028175A1 (en) | 2008-09-08 | 2010-03-11 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase activity and methods of use thereof |
| EP2349279A4 (en) | 2008-10-28 | 2013-12-25 | Univ Leland Stanford Junior | MODIFIERS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF |
| HUE026742T2 (en) | 2009-03-30 | 2016-07-28 | Ube Industries | A pharmaceutical composition for the treatment or prevention of glaucoma |
| DE102009049662A1 (de) | 2009-10-13 | 2011-04-14 | Bayer Schering Pharma Aktiengesellschaft | 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten |
| WO2012149106A1 (en) | 2011-04-29 | 2012-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
| TW201326154A (zh) | 2011-11-28 | 2013-07-01 | 拜耳知識產權公司 | 作為ｅｐ２受體拮抗劑之新穎２ｈ－吲唑 |
| KR20150135332A (ko) | 2013-03-14 | 2015-12-02 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA67754C2 (uk) | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
-
2003
- 2003-01-14 PY PY200300300568A patent/PY0300568A/es unknown
- 2003-01-20 OA OA1200400198A patent/OA12760A/en unknown
- 2003-01-20 EP EP03700072A patent/EP1470109A1/en not_active Withdrawn
- 2003-01-20 CA CA002473984A patent/CA2473984A1/en not_active Abandoned
- 2003-01-20 AP APAP/P/2004/003094A patent/AP2004003094A0/en unknown
- 2003-01-20 KR KR10-2004-7011618A patent/KR20040077884A/ko not_active Ceased
- 2003-01-20 CN CNA038029952A patent/CN1625549A/zh active Pending
- 2003-01-20 IL IL16216703A patent/IL162167A0/xx unknown
- 2003-01-20 HU HU0500012A patent/HUP0500012A2/hu unknown
- 2003-01-20 PL PL03371982A patent/PL371982A1/xx not_active Application Discontinuation
- 2003-01-20 BR BR0307339-4A patent/BR0307339A/pt not_active IP Right Cessation
- 2003-01-20 MX MXPA04004960A patent/MXPA04004960A/es unknown
- 2003-01-20 EA EA200400724A patent/EA200400724A1/ru unknown
- 2003-01-20 WO PCT/IB2003/000121 patent/WO2003064391A1/en not_active Ceased
- 2003-01-20 GB GB0413967A patent/GB2400100B/en not_active Expired - Fee Related
- 2003-01-20 HR HR20040683A patent/HRP20040683A2/hr not_active Application Discontinuation
- 2003-01-20 JP JP2003564014A patent/JP2005521668A/ja active Pending
- 2003-01-24 TW TW092101619A patent/TW200302080A/zh unknown
- 2003-01-28 HN HN2003000051A patent/HN2003000051A/es unknown
- 2003-01-28 PE PE2003000086A patent/PE20030978A1/es not_active Application Discontinuation
- 2003-01-29 US US10/353,671 patent/US6852863B2/en not_active Expired - Fee Related
- 2003-01-29 AR ARP030100254A patent/AR038332A1/es unknown
- 2003-01-30 PA PA20038564601A patent/PA8564601A1/es unknown
- 2003-01-30 UY UY27632A patent/UY27632A1/es not_active Application Discontinuation
-
2004
- 2004-05-21 IS IS7281A patent/IS7281A/is unknown
- 2004-05-25 ZA ZA200404067A patent/ZA200404067B/en unknown
- 2004-07-21 MA MA27796A patent/MA27169A1/fr unknown
- 2004-07-27 TN TNP2004000138A patent/TNSN04138A1/fr unknown
- 2004-07-30 EC EC2004005215A patent/ECSP045215A/es unknown
- 2004-08-26 NO NO20043569A patent/NO20043569D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN04138A1 (fr) | 2007-03-12 |
| IS7281A (is) | 2004-05-21 |
| NO20043569L (no) | 2004-08-26 |
| AR038332A1 (es) | 2005-01-12 |
| PL371982A1 (en) | 2005-07-11 |
| BR0307339A (pt) | 2004-12-07 |
| AP2004003094A0 (en) | 2004-09-30 |
| US6852863B2 (en) | 2005-02-08 |
| IL162167A0 (en) | 2005-11-20 |
| GB0413967D0 (en) | 2004-07-28 |
| UY27632A1 (es) | 2003-08-29 |
| GB2400100B (en) | 2006-04-12 |
| EP1470109A1 (en) | 2004-10-27 |
| HRP20040683A2 (en) | 2004-10-31 |
| TW200302080A (en) | 2003-08-01 |
| GB2400100A (en) | 2004-10-06 |
| HN2003000051A (es) | 2003-09-24 |
| JP2005521668A (ja) | 2005-07-21 |
| KR20040077884A (ko) | 2004-09-07 |
| WO2003064391A1 (en) | 2003-08-07 |
| HUP0500012A2 (hu) | 2005-04-28 |
| ZA200404067B (en) | 2005-08-29 |
| EA200400724A1 (ru) | 2004-12-30 |
| CN1625549A (zh) | 2005-06-08 |
| ECSP045215A (es) | 2004-09-28 |
| US20030216445A1 (en) | 2003-11-20 |
| OA12760A (en) | 2006-07-04 |
| NO20043569D0 (no) | 2004-08-26 |
| MXPA04004960A (es) | 2005-04-08 |
| MA27169A1 (fr) | 2005-01-03 |
| CA2473984A1 (en) | 2003-08-07 |
| PE20030978A1 (es) | 2003-11-19 |
| PA8564601A1 (es) | 2003-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PY0300568A (es) | Metabolitos del acido(3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi)acetico | |
| CY1113362T1 (el) | Διαρυλ-αιθερες, ως ανταγωνιστης οπιοειδους υποδοχεως | |
| ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
| GT200400277A (es) | Procedimiento de preparacion | |
| CR8827A (es) | Compuesto heterociclico fusionado | |
| CY1113578T1 (el) | 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια | |
| HN1997000110A (es) | Derivados del acido arilsulfoonilamino hidroxamico | |
| ECSP095220A (es) | Derivados de n-fenil-2-pirimidin-amina | |
| AU2003229953A1 (en) | Phthalazinone derivatives | |
| CR8640A (es) | Proceso para producir un compuesto de 5-hidroxi-4-tiometilpirazol | |
| AU2005240213A8 (en) | Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate | |
| PA8563901A1 (es) | Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico | |
| NO20054669L (no) | Substituerte kinobenzoxazinanaloger | |
| BR0313969A (pt) | Inibidores de oxitocina | |
| HN2000000031A (es) | Inhibidores de acido abierto y sales de dihidrolixilo de redustosa hmg-co-a. | |
| HRP20080057T3 (en) | 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof | |
| MXPA05010398A (es) | Nuevo metodo para la sintesis del acido (2s)-indolin-2-carboxilico y aplicacion de mismo en la sintesis del perindopril. | |
| EA200600898A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
| AU2003251681A1 (en) | Ghrelin binding nucleic acids | |
| ID30435A (id) | Proses-proses untuk menyiapkan perantara-perantara pestisidal | |
| EA200700364A1 (ru) | Производные амида кинуреновой кислоты как антагонисты nr2b подтипа рецептора nmda | |
| DOP2003000559A (es) | Metabolitos del acido (3-(4-terc-butilbencil)-(piridin-3-sulfonil)amino) metil fenoxi acetico. | |
| ATE466003T1 (de) | Herstellung von 2-aminothiazol-5- carbonsäurederivaten | |
| EA200601086A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
| BRPI0413686A (pt) | processo para a preparação ésteres dialquìlicos de ácido alfa-fluormalÈnico |